Pazopanib in Second-line Therapy in Renal Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aranzazu González del Alba, MD
Hospital Son Espases
Principal Investigator - Emilio Esteban, MD
Hospital Universitario Central de Asturias
Principal Investigator - Enrique Gallardo, MD
Corporació Sanitaria Parc Taulí
Principal Investigator - Jose Angel Arranz, MD
Hospital General Universitario Gregorio Marañón
Principal Investigator - José Luis González Larriba, MD
Hospital San Carlos, Madrid
Principal Investigator - Juan Manuel Sepúlveda, MD
Hospital 12 de Octubre
Principal Investigator - Marta Guix, MD
Hospital del Mar
Principal Investigator - Olatz Etxaniz, MD
Germans Trias i Pujol Hospital
Principal Investigator - Pablo Maroto, MD
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Principal Investigator - Xavier García del Muro, MD
Hospital Universitari de Bellvitge
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Son Espases
Palma de Mallorca, Balearic Islands, Spain
- Hospital Universitari Germans Trias I Pujol
Badalona, Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Barcelona, Spain
- Hospital del Mar
Barcelona, Barcelona, Spain
- Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain
- Corporació Sanitaria Parc Taulí
Sabadell, Barcelona, Spain
- Hospital 12 de Octubre
Madrid, Madrid, Spain
- Hospital Clínico San Carlos
Madrid, Madrid, Spain
- Hospital General Universitario Gregorio Marañón
Madrid, Madrid, Spain
- Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2012
- Primary completion
- 31 Oct 2014
- Completion
- 31 Oct 2015
- Last update posted
- 12 Mar 2014
- Registered enrollment
- 27
- Registry id
- NCT01577784
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.